2:57 PM
Nov 14, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: T cell lymphoma; leukemia

Patient sample and mouse studies suggest chimeric antigen receptor (CAR) T cells targeting TRBC1 could help treat TRBC1-positive T cell lymphomas and T cell leukemias. In cultures of T...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >